358 related articles for article (PubMed ID: 27835572)
1. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
Cheng JC; Chang HM; Xiong S; So WK; Leung PC
Oncotarget; 2016 Dec; 7(49):81645-81660. PubMed ID: 27835572
[TBL] [Abstract][Full Text] [Related]
2. Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
So WK; Cheng JC; Liu Y; Xu C; Zhao J; Chang VT; Leung PC
Tumour Biol; 2016 Jul; 37(7):9197-207. PubMed ID: 26768617
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression.
So WK; Fan Q; Lau MT; Qiu X; Cheng JC; Leung PC
FEBS Lett; 2014 Nov; 588(21):3998-4007. PubMed ID: 25261255
[TBL] [Abstract][Full Text] [Related]
4. Loss of Sprouty2 in human high-grade serous ovarian carcinomas promotes EGF-induced E-cadherin down-regulation and cell invasion.
So WK; Cheng JC; Fan Q; Wong AS; Huntsman DG; Gilks CB; Leung PC
FEBS Lett; 2015 Jan; 589(3):302-9. PubMed ID: 25533808
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-α induces human ovarian cancer cell invasion by down-regulating E-cadherin in a Snail-independent manner.
Qiu X; Cheng JC; Klausen C; Fan Q; Chang HM; So WK; Leung PC
Biochem Biophys Res Commun; 2015 May; 461(1):128-35. PubMed ID: 25869072
[TBL] [Abstract][Full Text] [Related]
6. HER2 mediates epidermal growth factor-induced down-regulation of E-cadherin in human ovarian cancer cells.
Cheng JC; Qiu X; Chang HM; Leung PC
Biochem Biophys Res Commun; 2013 Apr; 434(1):81-6. PubMed ID: 23542467
[TBL] [Abstract][Full Text] [Related]
7. Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells.
Cheng JC; Chang HM; Leung PC
Oncogene; 2013 Feb; 32(8):1041-9. PubMed ID: 22508482
[TBL] [Abstract][Full Text] [Related]
8. Betacellulin induces Slug-mediated down-regulation of E-cadherin and cell migration in ovarian cancer cells.
Zhao J; Klausen C; Qiu X; Cheng JC; Chang HM; Leung PC
Oncotarget; 2016 May; 7(20):28881-90. PubMed ID: 27129169
[TBL] [Abstract][Full Text] [Related]
9. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity.
Barbáchano A; Ordóñez-Morán P; García JM; Sánchez A; Pereira F; Larriba MJ; Martínez N; Hernández J; Landolfi S; Bonilla F; Pálmer HG; Rojas JM; Muñoz A
Oncogene; 2010 Aug; 29(34):4800-13. PubMed ID: 20543868
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells.
Cheng JC; Klausen C; Leung PC
Cancer Lett; 2013 Feb; 329(2):197-206. PubMed ID: 23142284
[TBL] [Abstract][Full Text] [Related]
11. Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signaling.
Bolitho C; Moscova M; Baxter RC; Marsh DJ
Mol Cell Endocrinol; 2021 Aug; 533():111338. PubMed ID: 34062166
[TBL] [Abstract][Full Text] [Related]
12. hCG-induced Sprouty2 mediates amphiregulin-stimulated COX-2/PGE2 up-regulation in human granulosa cells: a potential mechanism for the OHSS.
Cheng JC; Fang L; Chang HM; Sun YP; Leung PC
Sci Rep; 2016 Aug; 6():31675. PubMed ID: 27539669
[TBL] [Abstract][Full Text] [Related]
13. Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer.
Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
Int J Cancer; 2015 Aug; 137(3):560-70. PubMed ID: 25630587
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
15. Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells.
Feng YH; Tsao CJ; Wu CL; Chang JG; Lu PJ; Yeh KT; Shieh GS; Shiau AL; Lee JC
Cancer Sci; 2010 Sep; 101(9):2033-8. PubMed ID: 20624167
[TBL] [Abstract][Full Text] [Related]
16. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression.
Cheng JC; Chang HM; Leung PC
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1380-9. PubMed ID: 22569238
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of microRNA‑27b contributes to the migration and invasion of gastric cancer cells via the inhibition of sprouty2‑mediated ERK signaling.
Jiang J; Yi B; Qin C; Ding S; Cao W
Mol Med Rep; 2016 Mar; 13(3):2267-72. PubMed ID: 26781754
[TBL] [Abstract][Full Text] [Related]
19. Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression.
Xu Y; Yang X; Li Z; Li S; Guo S; Ismail S; Liu H; Huang Z; Zhang Z; Chen Y; Sun Q
Oncotarget; 2017 Jan; 8(3):4888-4900. PubMed ID: 28002800
[TBL] [Abstract][Full Text] [Related]
20. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
